Anti-influenza drug Tamiflu has been accused of side effects or can lead to death

Recently, a study conducted by the Japan Medical Nonprofit Center “Pharmaceutical Alert Center” showed that Tamiflu, an anti-influenza drug, may cause sudden and severe respiratory distress and other symptoms, and even lead to death. Tamiflu (also known as oseltamivir) is an anti-influenza drug developed by Swiss Roche Pharmaceuticals. In this regard, the reporter opened a mobile phone to the relevant person in the Roche Public Relations Department in China. The person said that the person responsible should be responsible for this matter, and the fixed-line telephone of the special person in charge has not been answered. According to media reports, the survey was based on data published by the Ministry of Health, Labour and Welfare of Japan. The results showed that of the 119 deaths in which Duffy was taken, 38 people had severe symptoms or died within 12 hours of taking the drug. Of the 15 patients who died of flu, zanamivir (alias Reliar sand), no one experienced worsening symptoms within 12 hours.

According to the data, Tamiflu was listed on the market in October 1999. The initial response was modest and the sales volume was not good. By 2002, a total of more than 5.5 million boxes were sold (a box containing 10 tablets of 75 mg of Duffy, equivalent to a course of treatment. Medications). However, the outbreak of bird flu has allowed Tamiflu to "run from time to time." Due to fears that bird flu will spread among the population, the World Health Organization has recommended that Tamiflu be prepared for storage. All governments have sent orders to Roche Pharmaceuticals.

The inquiry found that as an anti-influenza star, Duffy was not investigated for the first time. Japan is a big country with Duffy. In 2007, the Japanese government decided to investigate the anti-flu drug Tamiflu to determine whether it would lead to abnormal behaviour of some flu patients. Since then, the US FDA has also issued warnings about side effects that may cause mental disorders in patients, especially children. Although he did not recognize the connection between Tamiflu and mental disorders, Roche has also revised the description of Tamiflu and added the content of its spiritual influence.

According to Bian Chenguang, an analyst with the pharmaceutical industry at Anbang Consulting Group, it is normal for various side effects to occur during the drug listing process. Therefore, companies must actively collect information on adverse drug reactions after the drug market and update them according to adverse drug reactions. Drug Instructions.